Osiris Therapeutics appoints Thomas Brandt to the Board as Independent Director

– USA, MD – Osiris Therapeutics, Inc. (NASDAQ: OSIR), a leading cellular and regenerative medicine company focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, is pleased to announce that its Board of Directors, at a Board Meeting on March 3rd, 2016, confirmed the appointment of Dwayne Montgomery as the President and Chief Executive Officer.…

Sun BioPharma adds Dr Dalvir Gill to its Board as Independent Director

– USA, FL – Sun BioPharma, Inc., (OTCPink:SNBP), a biopharmaceutical company developing therapies for pancreatic diseases whose lead product candidate, SBP-101, has recently entered first in human clinical trials, today announced the appointment of Dr.…